NASDAQ$ATRC
Atricure Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Reported fourth quarter and full year financial results.
AtriCure reported a revenue of $88.0 million for the fourth quarter of 2022, representing a 20.2% increase compared to the fourth quarter of 2021. The company's loss from operations decreased to $4.1 million, and the net loss per share was $0.09.
- Worldwide revenue reached $88.0 million, up 20.2% year over year (21.5% on a constant currency basis).
- U.S. revenue increased by 20.7% to $73.9 million, driven by growth in open ablation, pain management, and appendage management product lines.
- International revenue grew by 17.8% to $14.1 million (25.4% on a constant currency basis), reflecting growth in appendage management and open ablation franchises.
- Loss from operations improved to $4.1 million compared to $12.5 million in the fourth quarter of 2021.
Headline financials
Revenue & EPS history
Atricure · Revenue · Quarterly
$88M
Revenue by segment
Atricure · $136M total across 8 segments · Q2 2025
- Appendage management US$45.1M—33.1%
- Open ablation US$36.5M—26.8%
- Pain management US$21.2M—15.5%
- Appendage management International$10.8M—7.9%
- Open ablation International$10.3M—7.6%
- Minimally invasive ablation US$7.84M—5.8%
- Minimally invasive ablation International$2.37M—1.7%
- Pain management International$2.03M—1.5%
Forward guidance
Full year 2023 revenue is projected to be approximately $380 million to $387 million, reflecting growth of approximately 15% to 17% over full year 2022. Full year 2023 adjusted EBITDA is expected to break even, with improvements annually thereafter. Full year 2023 adjusted loss per share is expected to be in the range of $1.14 to $1.19.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2022
+0.7%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.3%
Avg return
30 days after
48%
31 / 64 earnings
Positive
+21.1%
Q3 2024
Best reaction
-13.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -4.0% | -10.5% | -7.9% | |
| Q4 2025 | -2.3% | -3.6% | -11.5% | |
| Q3 2025 | -3.7% | -7.6% | +1.9% | |
| Q1 2025 | -13.7% | -16.1% | -0.2% | |
| Q4 2024 | -6.5% | -9.8% | -21.4% | |
| Q3 2024 | +21.1% | +16.6% | +25.8% | |
| Q2 2024 | -1.8% | +0.4% | +17.6% | |
| Q1 2024 | -7.9% | -8.4% | -6.6% | |
| Q4 2023 | +0.6% | +1.4% | -1.2% | |
| Q3 2023 | +5.6% | +9.3% | +5.6% | |
| Q2 2023 | +8.2% | +3.8% | -14.6% | |
| Q1 2023 | +7.1% | +7.1% | +1.5% | |
| Q4 2022 | +5.3% | -1.3% | -5.9% | |
| Q3 2022 | -4.2% | -5.9% | +9.1% | |
| Q2 2022 | +1.1% | +4.3% | -11.9% | |
| Q1 2022 | -2.6% | -17.8% | -21.4% | |
| Q4 2021 | +5.8% | -3.8% | +2.2% | |
| Q3 2021 | +10.0% | +9.2% | -16.0% | |
| Q2 2021 | -2.5% | -5.4% | -8.6% | |
| Q1 2021 | +5.8% | +16.8% | +11.5% | |
| Q4 2020 | -4.3% | +0.1% | -4.3% | |
| Q3 2020 | +0.2% | +6.8% | +25.8% | |
| Q2 2020 | -7.2% | -10.7% | -8.8% | |
| Q1 2020 | +10.0% | +4.7% | +22.0% | |
| Q4 2019 | -3.8% | -10.1% | -37.9% | |
| Q3 2019 | -2.8% | +4.4% | +8.7% | |
| Q2 2019 | +1.3% | -0.3% | -13.9% | |
| Q1 2019 | +4.8% | +7.4% | +5.5% | |
| Q4 2018 | -5.6% | -8.4% | -17.8% | |
| Q3 2018 | -1.4% | +0.7% | +5.3% | |
| Q2 2018 | +11.2% | +7.2% | +20.6% | |
| Q1 2018 | +9.5% | +7.8% | +18.2% | |
| Q4 2017 | +5.5% | +1.9% | +11.2% | |
| Q3 2017 | -8.7% | -12.3% | -13.6% | |
| Q2 2017 | +3.0% | -0.4% | -7.8% | |
| Q1 2017 | +9.4% | +5.5% | +2.0% | |
| Q4 2016 | +4.9% | -5.5% | +1.1% | |
| Q3 2016 | +7.3% | +9.0% | +17.5% | |
| Q2 2016 | -10.7% | -4.2% | +4.8% | |
| Q1 2016 | -10.4% | — | — | |
| Q4 2015 | -5.5% | — | — | |
| Q3 2015 | -0.7% | — | — | |
| Q2 2015 | +14.5% | — | — | |
| Q1 2015 | +7.6% | — | — | |
| Q4 2014 | -4.4% | — | — | |
| Q3 2014 | +2.8% | — | — | |
| Q2 2014 | -4.4% | — | — | |
| Q1 2014 | -2.3% | — | — | |
| Q4 2013 | -0.9% | — | — | |
| Q3 2013 | +1.1% | — | — | |
| Q2 2013 | +0.9% | — | — | |
| Q1 2013 | +9.1% | — | — | |
| Q4 2012 | +5.6% | — | — | |
| Q3 2012 | +20.3% | — | — | |
| Q2 2012 | -6.7% | — | — | |
| Q1 2012 | -5.1% | — | — | |
| Q4 2011 | -4.7% | — | — | |
| Q3 2011 | -5.0% | — | — | |
| Q2 2011 | -13.2% | — | — | |
| Q1 2011 | +2.6% | — | — | |
| Q4 2010 | +2.6% | — | — | |
| Q3 2010 | -0.6% | — | — | |
| Q2 2010 | -0.4% | — | — | |
| Q1 2010 | -1.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro